Antiangiogenesis in the treatment of NSCLC. Part 2 of a 3-part series: Targeting VEGF - Current and future research directions

Roy S. Herbst, Alan B. Sandler, David H. Johnson

Research output: Contribution to journalEditorialpeer-review

Fingerprint

Dive into the research topics of 'Antiangiogenesis in the treatment of NSCLC. Part 2 of a 3-part series: Targeting VEGF - Current and future research directions'. Together they form a unique fingerprint.

Medicine & Life Sciences